Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/136272
Title: A PROANGIOGENIC STRATEGY TO PROMOTE DIABETIC WOUND CLOSURE
Authors: LIM SHENG JIE NATALIE
Keywords: Granulation tissue, Angiogenesis, Diabetic wound healing, Ciclopirox Olamine, Sphingosine-1-phosphate, Zucker diabetic fatty rats
Issue Date: 15-Dec-2016
Source: LIM SHENG JIE NATALIE (2016-12-15). A PROANGIOGENIC STRATEGY TO PROMOTE DIABETIC WOUND CLOSURE. ScholarBank@NUS Repository.
Abstract: This dissertation seeks to repurpose two drugs 1)antifungal ciclopirox olamine(CPX) and 2)lysophospholipid sphingosine-1-phosphate(S1P) as a proangiogenic combination to promote diabetic skin wound contraction. Contraction involves compaction of collagen fibers in the granulation tissue which pulls the perilesional skin to reduce wound area. This process requires a robust angiogenesis. In diabetics, both angiogenesis and contraction are diminished, impairing wound healing. To emulate this pathology and address it pharmacologically, a wound healing model in diabetic ZDF rats is developed and topically treated with CPX+S1P. In vitro, CPX+S1P upregulates a crucial driver of angiogenesis, hypoxia-inducible factor-1. Injection of CPX+S1P into subcutaneously implanted sponges additively increased endothelial infiltration and vessel length. Identification of specific dorsal sites in diabetic rats allowed for incremental wound depths from 1mm (superficial) to 3mm (deep). While the effects of topical gel treatment of CPX+S1P were masked by rodent-characteristic dominant contraction in superficial wounds, they became evident in deep wounds.
URI: http://scholarbank.nus.edu.sg/handle/10635/136272
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
LimSJN.pdf8.89 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

25
checked on Jan 14, 2018

Download(s)

367
checked on Jan 14, 2018

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.